Open Access

Staphylococcal Toxic Shock Syndrome Caused By An Intravaginal Product. A Case Report

   | Feb 09, 2016

Cite

1. De Rosa FG, Corcione S, Motta I, et al. Risk factors for mortality in patients with Staphylococcus aureus bloodstream infection. J Chemother. 2015:1973947815Y0000000076. [Epub ahead of print]Search in Google Scholar

2. Klug CD, Keay CR, Ginde AA. Fatal toxic shock syndrome from an intrauterine device. Ann Emerg Med. 2009;54:701-3.10.1016/j.annemergmed.2009.05.030Search in Google Scholar

3. David M, Daum R. Community-Associated Methicillin- Resistant Staphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic. Clin Microbiol Rev. 2010;23:616-87.10.1128/CMR.00081-09Search in Google Scholar

4. Stingley RL, Liu H, Mullis LB, Elkins CA, Hart ME. Staphylococcus aureus toxic shock syndrome toxin-1 (TSST-1) production and Lactobacillus species growth in a defined medium simulating vaginal secretions. J Microbiol Methods. 2014;106:57-66.10.1016/j.mimet.2014.08.002Search in Google Scholar

5. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev. 1997;10:505-20.10.1128/CMR.10.3.505Search in Google Scholar

6. Diawara I, Bekhti K, Elhabchi D, et al. Staphylococcus aureus nasal carriage in hemodialysis centers of Fez, Morocco. Iran J Microbiol. 2014;6:175-83.Search in Google Scholar

7. Todd J, Fishaut M, Kapral F, Welch T. Toxic-shock syndrome associated with phage-group-I Staphylococci. Lancet. 1978;2:1116-8.10.1016/S0140-6736(78)92274-2Search in Google Scholar

8. Chan Y, Selvaratnam V, Garg N. Toxic shock syndrome post open reduction and Kirschner wire fixation of a humeral lateral condyle fracture. BMJ Case Rep. 2015;2015. pii: bcr2015210090.10.1136/bcr-2015-210090453362726264942Search in Google Scholar

9. Jiang W, Zhou Z, Zhang K, Yu Y. Epidemiological investigation of community-acquired Staphylococcus aureus infection. Genet Mol Res. 2013;12:6923-30.10.4238/2013.December.19.1124391040Search in Google Scholar

10. Ono HK, Sato’o Y, Narita K, et al. Identification and Characterization of a Novel Staphylococcal Emetic Toxin. Appl Environ Microbiol. 2015;81:7034-40.10.1128/AEM.01873-15457945926231643Search in Google Scholar

11. Le Moing V, Alla F, Doco-Lecompte T, et al. Staphylococcus aureus Bloodstream Infection and Endocarditis - A Prospective Cohort Study. PLoS One. 2015;10:e0127385.10.1371/journal.pone.0127385444745226020939Search in Google Scholar

12. Paulsen J, Mehl A, A, Solligard E, Asvold BO, Damas JK. Epidemiology and outcome of Staphylococcus aureus bloodstream infection and sepsis in a Norwegian county 1996-2011: an observational study. BMC Infect Dis. 2015;15:116.10.1186/s12879-015-0849-4435168125887177Search in Google Scholar

13. Ekpe K, Novara A, Mainardi JL, Fagon JY, Faisy C. Methicillinresistant Staphylococcus aureus bloodstream infections are associated with a higher energy deficit than other ICU-acquired bacteremia. Intensive Care Med. 2014;40:1878-87.10.1007/s00134-014-3502-625288210Search in Google Scholar

14. Mitchell MA, Bisch S, Arntfield S, Hosseini-Moghaddam SM. A confirmed case of toxic shock syndrome associated with the use of a menstrual cup. Can J Infect Dis Med Microbiol. 2015;26:218-20.10.1155/2015/560959455618426361491Search in Google Scholar

15. Lachant DJ, Apostolakos M, Pietropaoli A. Methicillin Resistant Staphylococcus aureus Prostatic Abscess with Bacteremia. Case Rep Infect Dis. 2013;2013:613961.Search in Google Scholar

16. Honarpisheh H, Camp R, Lazova R. Staphylococcal Purpura Fulminans: Report of a Case. Am J Dermatopathol. 2015;37:643-6.10.1097/DAD.000000000000017525099358Search in Google Scholar

17. El Zakhem A, Chaftari AM, Bahu R, et al. Central line-associated bloodstream infections caused by Staphylococcus aureus in cancer patients: Clinical outcome and management. Ann Med. 2014;46:163-8.10.3109/07853890.2013.87851324491173Search in Google Scholar

18. Dinges MM, Orwin P, Schlievert P. Exotoxins of Staphyloccocus aureus. Clin Microbiol Rev. 2000;13:16-34.10.1128/CMR.13.1.168893110627489Search in Google Scholar

19. Tilahun AY, Karau M, Ballard A, et al. The impact of Staphylococcus aureus-associated molecular patterns on staphylococcal superantigen-induced toxic shock syndrome and pneumonia. Mediators Inflamm. 2014;2014:468285.10.1155/2014/468285408293025024509Search in Google Scholar

20. Low DE. Toxic shock syndrome: major advances in pathogenesis, but not treatment. Crit Care Clin. 2013;29:651-75.10.1016/j.ccc.2013.03.01223830657Search in Google Scholar

21. DeVries AS, Lesher L, Schlievert PM, et al. Staphylococcal toxic shock syndrome 2000-2006: epidemiology, clinical features, and molecular characteristics. PLoS One. 2011;6:e22997.10.1371/journal.pone.0022997315791021860665Search in Google Scholar

eISSN:
2393-1817
Language:
English